Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Chaisson

Showing results (61-70 of 226) with videos related to

Pageof 23
Sort By:
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
HIV antigen variability in ARC/AIDSC W Hendrix, P A Volberding, R E Chaisson
The Journal of Infectious Diseases|November 1, 1993
Herpes zoster in patients with advanced human immunodeficiency virus infection treated with zidovudine. Zidovudine Epidemiology Study GroupM J Glesby, R D Moore, R E Chaisson
AIDS (London, England)|November 8, 2001
HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapyT R Sterling, R E Chaisson, R D Moore
AIDS (London, England)|September 8, 2001
Comparison of initial combination antiretroviral therapy with a single protease inhibitor, ritonavir and saquinavir, or efavirenzG M Lucas, R E Chaisson, R D Moore
Chest|November 21, 1998
The effect of adjunctive corticosteroids for the treatment of Pneumocystis carinii pneumonia on mortality and subsequent complicationsJ E Gallant, R E Chaisson, R D Moore
AIDS (London, England)|June 21, 2001
Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapyK E Poundstone, R E Chaisson, R D Moore
Journal of Acquired Immune Deficiency Syndromes (1999)|October 2, 2001
Increasing incidence of avascular necrosis of the hip in HIV-infected patientsJ C Keruly, R E Chaisson, R D Moore
Science (New York, N.Y.)|January 13, 1978
Oil spills and offshore drillingR E Chaisson, L B Smith, J M Fay
The Western Journal of Medicine|July 1, 1996
Prophylaxis against opportunistic infections in patients infected with the human immunodeficiency virusL W Cheever, R E Chaisson, J E Gallant
The American Journal of Medicine|July 1, 1996
Adverse events from drug therapy for human immunodeficiency virus diseaseR D Moore, I Fortgang, J Keruly, et al.
Pageof 23

Showing results (61-70 of 226) with videos related to

Sort By:
Pageof 23
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
HIV antigen variability in ARC/AIDSC W Hendrix, P A Volberding, R E Chaisson
The Journal of Infectious Diseases|November 1, 1993
Herpes zoster in patients with advanced human immunodeficiency virus infection treated with zidovudine. Zidovudine Epidemiology Study GroupM J Glesby, R D Moore, R E Chaisson
AIDS (London, England)|November 8, 2001
HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapyT R Sterling, R E Chaisson, R D Moore
AIDS (London, England)|September 8, 2001
Comparison of initial combination antiretroviral therapy with a single protease inhibitor, ritonavir and saquinavir, or efavirenzG M Lucas, R E Chaisson, R D Moore
Chest|November 21, 1998
The effect of adjunctive corticosteroids for the treatment of Pneumocystis carinii pneumonia on mortality and subsequent complicationsJ E Gallant, R E Chaisson, R D Moore
AIDS (London, England)|June 21, 2001
Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapyK E Poundstone, R E Chaisson, R D Moore
Journal of Acquired Immune Deficiency Syndromes (1999)|October 2, 2001
Increasing incidence of avascular necrosis of the hip in HIV-infected patientsJ C Keruly, R E Chaisson, R D Moore
Science (New York, N.Y.)|January 13, 1978
Oil spills and offshore drillingR E Chaisson, L B Smith, J M Fay
The Western Journal of Medicine|July 1, 1996
Prophylaxis against opportunistic infections in patients infected with the human immunodeficiency virusL W Cheever, R E Chaisson, J E Gallant
The American Journal of Medicine|July 1, 1996
Adverse events from drug therapy for human immunodeficiency virus diseaseR D Moore, I Fortgang, J Keruly, et al.
Pageof 23